title: Sofosbuvir and daclatasvir.
authors.affiliation: Leiden University Medical Center, Leiden.
authors.forename: Marleen H M
authors.initials: MH
authors.lastname: Hessel
authors.affiliation: Leiden University Medical Center, Leiden.|Center for Human Drug Research, Leiden, the Netherlands.
authors.forename: Adam F
authors.identifier: 0000-0001-7452-6222
authors.initials: AF
authors.lastname: Cohen
authors.affiliation: Leiden University Medical Center, Leiden.|Center for Human Drug Research, Leiden, the Netherlands.
authors.forename: Robert
authors.initials: R
authors.lastname: Rissmann
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D002219:Carbamates; D016174:Hepacivirus / Q000187:drug effects; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D011759:Pyrrolidines; D000069474:Sofosbuvir / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D014633:Valine / Q000031:analogs & derivatives
chemical_list: D000998:Antiviral Agents; D002219:Carbamates; D007093:Imidazoles; D011759:Pyrrolidines; D014633:Valine; C549273:daclatasvir; D000069474:Sofosbuvir